FCMI

Foresite Capital Management III Portfolio holdings

AUM $37.9M
This Quarter Return
-2.59%
1 Year Return
-6.87%
3 Year Return
+443.49%
5 Year Return
+535.97%
10 Year Return
AUM
$262M
AUM Growth
+$262M
Cap. Flow
-$21.5M
Cap. Flow %
-8.21%
Top 10 Hldgs %
89.8%
Holding
18
New
Increased
3
Reduced
6
Closed
4
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
AERI
1
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
$45.2M 17.25% 2,350,477 +400,000 +21% +$7.69M
ALDR
2
DELISTED
Alder Biopharmaceuticals, Inc.
ALDR
$45.1M 17.24% 2,393,612 -548,518 -19% -$10.3M
BPMC
3
DELISTED
Blueprint Medicines
BPMC
$41.1M 15.69% 559,381 +91,699 +20% +$6.74M
IMMU
4
DELISTED
Immunomedics Inc
IMMU
$25.9M 9.91% 1,956,362 +17,750 +0.9% +$235K
ASND icon
5
Ascendis Pharma
ASND
$11.8B
$19.7M 7.51% 204,088
MYOK
6
DELISTED
MyoKardia, Inc. Common Stock
MYOK
$15.6M 5.95% 298,666 -15,734 -5% -$821K
AIMT
7
DELISTED
Aimmune Therapeutics, Inc.
AIMT
$12.8M 4.89% 611,893 -35,361 -5% -$740K
EPZM
8
DELISTED
Epizyme, Inc
EPZM
$10.3M 3.93% 998,278
XLRN
9
DELISTED
Acceleron Pharma Inc.
XLRN
$10.1M 3.85% 254,923
NTRA icon
10
Natera
NTRA
$23.1B
$9.4M 3.59% 286,468
BOLD
11
DELISTED
Audentes Therapeutics, Inc
BOLD
$8.86M 3.38% 315,331
REPL icon
12
Replimune Group
REPL
$422M
$7.92M 3.02% 569,662 -209,994 -27% -$2.92M
CBAY
13
DELISTED
Cymabay Therapeutics
CBAY
$7.72M 2.95% 1,508,091 -79,010 -5% -$405K
BHVN
14
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$2.23M 0.85% 53,345 -11,904 -18% -$497K
FBRX icon
15
Forte Biosciences
FBRX
$137M
-568,054 Closed -$3.8M
RCUS icon
16
Arcus Biosciences
RCUS
$1.13B
-1,366,973 Closed -$10.9M
WVE icon
17
Wave Life Sciences
WVE
$1.53B
-139,900 Closed -$3.65M
BDSI
18
DELISTED
BioDelivery Sciences International, Inc.
BDSI
-454,656 Closed -$2.11M